Matthew E. Korenberg, EVP, Finance & Strategy and CFO at LIGAND PHARMACEUTICALS INC (LGND), sold 36,714 shares at $256.69 ($9.4M) on 2018-08-29, disclosed to the SEC on 2018-08-29.
Open-market sale of $9.4M LGND by EVP, Finance & Strategy and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $256.69 | 18,357 | $4.7M | 50.0% |
| 2 | $256.69 | 18,357 | $4.7M | 50.0% |
| Total | $256.69 avg | 36,714 | $9.4M | 100% |
| Filing → |
| LGND | SELL | 2024-08-13 | $3.6M | — | Filing → |
| LGND | SELL | 2024-05-15 | $2.9M | — | Filing → |
| LGND | BUY | 2019-09-03 | $43K | — | Filing → |